| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash received in acquisition | NaN | 0 | 0 | NaN |
| Acquisition of property and equipment | NaN | 0 | 0 | NaN |
| Investment in securities | NaN | 0 | 0 | 0 |
| Current liabilities | NaN | 0 | -5,441 | 0 |
| Net cash used in investing activities from continuing operations | NaN | 0 | 0 | 0 |
| Loss on disposition of subsidiaries | NaN | 0 | 171,042 | -385,528 |
| Change in fair value of derivative liability | 0 | 0 | 2,356,428 | -59,594 |
| Net cash provided by investing activities from discontinued operations | NaN | 0 | 0 | 0 |
| Loss on conversion of note payable | 0 | 0 | 43,200 | -96,646 |
| Net cash provided by investing activities | NaN | 0 | 0 | 0 |
| Common stock issued for services | 0 | 86,600 | 442,237 | 3,781,253 |
| Impairment of investment | NaN | 0 | NaN | NaN |
| Amortization of debt discount | 0 | 411,111 | 1,755,349 | 994,640 |
| Net loss from continuing operations | NaN | -30,115,211 | -3,607,361 | -9,784,570 |
| Other receivables | 0 | 0 | 0 | 80,469 |
| Depreciation expense | 500 | 500 | 500 | 1,000 |
| Amortization of intangible assets | 453,846 | 453,846 | NaN | NaN |
| Change in fair value of warrant liability | -10,914 | -127,709 | -59,203 | -722,108 |
| Options expense | NaN | NaN | NaN | 162,874 |
| Stock-based compensation | 102,320 | 248,459 | 1,820,433 | NaN |
| Amortization of right-of-use assets | 13,667 | 0 | 6,454 | 29,481 |
| Accounts receivable, net | -8,783 | 141,278 | 590,050 | -11,106 |
| Prepaid expenses and deposits | -11,851 | -21,189 | -67,876 | 282,088 |
| Inventory | -2,474 | -21,113 | 234,521 | 0 |
| Lease liability | -14,133 | 0 | -6,465 | -30,514 |
| Accounts payable | -38,473 | -2,229,596 | 707,465 | -45,084 |
| Goodwill impairment | NaN | 26,346,050 | NaN | NaN |
| Accrued liabilities | 46,838 | 37,132 | -772,068 | 486,362 |
| Net cash used in operating activities from continuing operations | NaN | -5,175,294 | -3,208,339 | -4,998,849 |
| Net loss | -3,402,264 | NaN | NaN | NaN |
| Net cash provided by (used in) operating activities from discontinued operations | NaN | 0 | -5,346 | 8,145 |
| Interest income | 93,750 | 187,500 | 0 | 62,500 |
| Net cash provided by (used in) financing activities from continuing operations | NaN | 11,481,610 | 3,553,986 | 4,697,999 |
| Net cash used in operating activities | -2,919,255 | -5,175,294 | -3,213,685 | -4,990,704 |
| Net cash used in financing activities from discontinued operations | NaN | 0 | 0 | 0 |
| Repayment of contingent liability | NaN | 0 | 0 | 0 |
| Repayment of loan payable, related party | NaN | 531,000 | NaN | NaN |
| Proceeds from convertible notes | NaN | 3,500,000 | 0 | NaN |
| Proceeds from issuance of convertible notes, net of issuance costs | NaN | 0 | NaN | NaN |
| Cash dividends paid | NaN | 0 | 0 | 0 |
| Proceeds from exercise of warrants | NaN | 0 | 0 | 0 |
| Proceeds from exercise of options | NaN | 0 | 0 | 0 |
| Proceeds from loan payable, related party | 0 | 0 | 16,000 | 100,000 |
| Deferred offering costs | NaN | NaN | NaN | 0 |
| Repayment of convertible notes | NaN | 5,911,111 | 3,333,333 | NaN |
| Gross proceeds from issuance of common stock | 0 | 14,823,721 | 6,871,319 | 4,597,999 |
| Repayment of development liability | 200,000 | 400,000 | NaN | NaN |
| Net cash (used in) provided by financing activities | -200,000 | 11,481,610 | 3,553,986 | 4,697,999 |
| Net change in cash | -3,119,255 | 6,306,316 | NaN | NaN |
| Net change in cash | -3,119,255 | 6,306,316 | 340,301 | -292,705 |
| Cash at beginning of period | 6,662,008 | 355,692 | 308,096 | NaN |
| Cash at end of period | 3,542,754 | 6,662,008 | 355,692 | NaN |
Scienture Holdings, Inc. (SCNX)
Scienture Holdings, Inc. (SCNX)